Category
All
New Technology
Service & Software
Internet & Communication
Electronics & Semiconductor
Pharma & Healthcare
Other
Energy & Power
Agriculture
Consumer Goods
Machinery & Equipment
Food & Beverages
Medical Care
Automobile & Transportation
Packaging
Chemical & Material
Medical Devices & Consumables
Category
All
Total: 2 records, 1 pages
Search For: Anti-amyloid Drugs
Global Anti-amyloid Drugs Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
27 Oct 2024
Pharma & Healthcare
Anti-amyloid drugs are therapeutic agents specifically designed to target and reduce the buildup of amyloid-beta plaques in the brain, a hallmark of Alzheimer’s disease.By binding to amyloid-beta or its aggregated forms, these medications aim to facilitate the removal of these harmful deposits from the brain, potentially slowing the progression of the disease and improving cognitive function in patients. Prominent examples include donanemab and lecanemab, which have been used to treat early stages of Alzheimer’s.
USD3480.00
Add To Cart
Global Anti-amyloid Drugs Supply, Demand and Key Producers, 2024-2030
27 Oct 2024
Pharma & Healthcare
Anti-amyloid drugs are therapeutic agents specifically designed to target and reduce the buildup of amyloid-beta plaques in the brain, a hallmark of Alzheimer’s disease.By binding to amyloid-beta or its aggregated forms, these medications aim to facilitate the removal of these harmful deposits from the brain, potentially slowing the progression of the disease and improving cognitive function in patients. Prominent examples include donanemab and lecanemab, which have been used to treat early stages of Alzheimer’s.
USD4480.00
Add To Cart
Popular Product Keywords
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
Search For: Anti-amyloid Drugs
Total: 2 records, 1 pages
Anti-amyloid drugs are therapeutic agents specifically designed to target and reduce the buildup of amyloid-beta plaques in the brain, a hallmark of Alzheimer’s disease.By binding to amyloid-beta or its aggregated forms, these medications aim to facilitate the removal of these harmful deposits from the brain, potentially slowing the progression of the disease and improving cognitive function in patients. Prominent examples include donanemab and lecanemab, which have been used to treat early stages of Alzheimer’s.
USD3480.00
Add To Cart
Anti-amyloid drugs are therapeutic agents specifically designed to target and reduce the buildup of amyloid-beta plaques in the brain, a hallmark of Alzheimer’s disease.By binding to amyloid-beta or its aggregated forms, these medications aim to facilitate the removal of these harmful deposits from the brain, potentially slowing the progression of the disease and improving cognitive function in patients. Prominent examples include donanemab and lecanemab, which have been used to treat early stages of Alzheimer’s.
USD4480.00
Add To Cart
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
-
Insight into the industry market information
-
Analyze market development needs
-
Prospects for future development
-
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>